tazarotene has been researched along with Insulin Resistance in 2 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence." | 1.56 | Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. ( Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menter, A | 1 |
| Cordoro, KM | 1 |
| Davis, DMR | 1 |
| Kroshinsky, D | 1 |
| Paller, AS | 1 |
| Armstrong, AW | 1 |
| Connor, C | 1 |
| Elewski, BE | 1 |
| Gelfand, JM | 1 |
| Gordon, KB | 1 |
| Gottlieb, AB | 1 |
| Kaplan, DH | 1 |
| Kavanaugh, A | 1 |
| Kiselica, M | 1 |
| Kivelevitch, D | 1 |
| Korman, NJ | 1 |
| Lebwohl, M | 1 |
| Leonardi, CL | 1 |
| Lichten, J | 1 |
| Lim, HW | 1 |
| Mehta, NN | 1 |
| Parra, SL | 1 |
| Pathy, AL | 1 |
| Farley Prater, EA | 1 |
| Rupani, RN | 1 |
| Siegel, M | 1 |
| Stoff, B | 1 |
| Strober, BE | 1 |
| Wong, EB | 1 |
| Wu, JJ | 1 |
| Hariharan, V | 1 |
| Elmets, CA | 1 |
| Weisshaar, E | 1 |
| Bonnekoh, B | 1 |
| Franke, I | 1 |
| Gollnick, H | 1 |
2 other studies available for tazarotene and Insulin Resistance
| Article | Year |
|---|---|
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiov | 2020 |
[Successful symptomatic tazarotene treatment of juvenile acanthosis nigricans of the familial obesity-associated type in insulin resistance].
Topics: Acanthosis Nigricans; Administration, Topical; Child; Diabetes Mellitus; Diabetes Mellitus, Type 2; | 2001 |